Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine

Journal of Thoracic and Cardiovascular Surgery

Volumn 135, Issue 1, 2008, Pages 117-122

  Boodhwani, Munir ^a   Mieno, Shigetoshi ^a   Feng, Jun ^a   Sodha, Neel R ^a   Clements, Richard T ^a   Xu, Shu Hua ^a   Sellke, Frank W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ANGIOPOIETIN RECEPTOR; ATORVASTATIN; ENDOSTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MICROSPHERE; NITROPRUSSIDE SODIUM; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; CELL DENSITY; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DRUG MECHANISM; ENDOTHELIUM; FEEDING; FEMALE; HEART DEVELOPMENT; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; IN VITRO STUDY; ISOTOPE LABELING; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; VASODILATATION;

ANIMALS; CHOLESTEROL; COLLATERAL CIRCULATION; CORONARY CIRCULATION; FEMALE; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MICROCIRCULATION; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; PYRROLES; SWINE;

EID: 37549069288     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.04.021     Document Type: Article

References (17)

1. Balk E.M., Karas R.H., Jordan H.S., Kupelnick B., Chew P., and Lau J. Effects of statins on vascular structure and function: a systematic review. Am J Med 117 (2004) 775-790
2. Collard C.D., Body S.C., Shernan S.K., Wang S., and Mangano D.T. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 132 (2006) 392-400
3. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
4. Urbich C., Dernbach E., Zeiher A.M., and Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 90 (2002) 737-744
5. Weis M., Heeschen C., Glassford A.J., and Cooke J.P. Statins have biphasic effects on angiogenesis. Circulation 105 (2002) 739-745
6. Kureishi Y., Luo Z., Shiojima I., Bialik A., Fulton D., Lefer D.J., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6 (2000) 1004-1010
7. Boodhwani M., Nakai Y., Voisine P., Feng J., Li J., Mieno S., et al. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response. Circulation 114 (2006) I402-I408
8. Boodhwani M., Mieno S., Voisine P., Feng J., Sodha N., Li J., et al. High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine. J Thorac Cardiovasc Surg 132 (2006) 1299-1306
9. Boodhwani M., Nakai Y., Mieno S., Voisine P., Bianchi C., Araujo E.G., et al. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg 81 (2006) 634-641
10. Park H.J., Kong D., Iruela-Arispe L., Begley U., Tang D., and Galper J.B. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 91 (2002) 143-150
11. Giurgea A.G., Margeta C., Maca T., Rezaie-Majd A., Bucek R.A., Manavi M., et al. Simvastatin reduces serum level of vascular endothelial growth factor in hypercholesterolemic patients. J Cardiovasc Pharmacol 47 (2006) 30-36
12. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
13. Nagoshi T., Matsui T., Aoyama T., Leri A., Anversa P., Li L., et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115 (2005) 2128-2138
14. Dhanabal M., Ramchandran R., Waterman M.J., Lu H., Knebelmann B., Segal M., et al. Endostatin induces endothelial cell apoptosis. J Biol Chem 274 (1999) 11721-11726
15. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
16. Libby P., and Aikawa M. Mechanisms of plaque stabilization with statins. Am J Cardiol 91 (2003) 4B-8B
17. Poynter J.N., Gruber S.B., Higgins P.D., Almog R., Bonner J.D., Rennert H.S., et al. Statins and the risk of colorectal cancer. N Engl J Med 352 (2005) 2184-2192